Putting pancreatic cell plasticity to the test

Por Ferrer, Jorge, Martín, Mercè, Servitja, Joan Marc
Publicado em 2007

Involvement of ET(A) and ET(B) receptors in the activation of phospholipase D by endothelins in cultured rat cortical astrocytes

Por Servitja, Joan-Marc, Masgrau, Roser, Sarri, Elisabet, Picatoste, Fernando
Publicado em 1998

Functional Targets of the Monogenic Diabetes Transcription Factors HNF-1α and HNF-4α Are Highly Conserved Between Mice and Humans

Por Boj, Sylvia F., Servitja, Joan Marc, Martin, David, Rios, Martin, Talianidis, Iannis, Guigo, Roderic, Ferrer, Jorge
Publicado em 2009

Chaperones Ameliorate Beta Cell Dysfunction Associated with Human Islet Amyloid Polypeptide Overexpression

Por Cadavez, Lisa, Montane, Joel, Alcarraz-Vizán, Gema, Visa, Montse, Vidal-Fàbrega, Laia, Servitja, Joan-Marc, Novials, Anna
Publicado em 2014

Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance

Por Sonia Servitja, Tamara Martos, Maria Rodriguez Sanz, Natalia Garcia-Giralt, Daniel Prieto-Alhambra, Laia Garrigos, Xavier Nogues, Ignasi Tusquets
Publicado em 2015-09-01

Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance

Por Servitja, Sonia, Martos, Tamara, Rodriguez Sanz, Maria, Garcia-Giralt, Natalia, Prieto-Alhambra, Daniel, Garrigos, Laia, Nogues, Xavier, Tusquets, Ignasi
Publicado no Ther Adv Med Oncol (2015)

Análisis genético de enzimas de la vía esteroidal asociadas a efectos adversos musculoesqueléticos delos inhibidores de la aromatasa

Por Pineda-Moncusí M, Rodríguez-Sanz M, Díez-Pérez A, Aymar I, Martos T, Servitja S, Tusquets I, García-Giralt N, Nogués X
Publicado em 2017-06-01

Nurr1 Protein Is Required for N-Methyl-d-aspartic Acid (NMDA) Receptor-mediated Neuronal Survival

Por Barneda-Zahonero, Bruna, Servitja, Joan-Marc, Badiola, Nahuai, Miñano-Molina, Alfredo J., Fadó, Rut, Saura, Carlos A., Rodríguez-Alvarez, José
Publicado em 2012

SEOM clinical guidelines in early-stage breast cancer 2015

Por Garcia-Saenz, J. A., Bermejo, B., Estevez, L. G., Palomo, A. G., Gonzalez-Farre, X., Margeli, M., Pernas, S., Servitja, S., Rodriguez, C. A., Ciruelos, E.
Publicado no Clin Transl Oncol (2015)

Hnf1α (MODY3) Controls Tissue-Specific Transcriptional Programs and Exerts Opposed Effects on Cell Growth in Pancreatic Islets and Liver

Por Servitja, Joan-Marc, Pignatelli, Miguel, Maestro, Miguel Ángel, Cardalda, Carina, Boj, Sylvia F., Lozano, Juanjo, Blanco, Enrique, Lafuente, Amàlia, McCarthy, Mark I., Sumoy, Lauro, Guigó, Roderic, Ferrer, Jorge
Publicado em 2009

Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel

Por Martínez-Jañez, Noelia, Chacón, Ignacio, de Juan, Ana, Cruz-Merino, Luis, del Barco, Sònia, Fernández, Isaura, García-Teijido, Paula, Gómez-Bernal, Amalia, Plazaola, Arrate, Ponce, José, Servitja, Sonia, Zamora, Pilar
Publicado no Breast Care (Basel) (2016)

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer

Por Dalmases, Alba, González, Irene, Menendez, Silvia, Arpí, Oriol, Corominas, Josep Maria, Servitja, Sonia, Tusquets, Ignasi, Chamizo, Cristina, Rincón, Raúl, Espinosa, Lluis, Bigas, Anna, Eroles, Pilar, Furriol, Jessica, Lluch, Anna, Rovira, Ana, Albanell, Joan, Rojo, Federico
Publicado em 2013

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program

Por Castells, Xavier, Domingo, Laia, Corominas, Josep María, Torá-Rocamora, Isabel, Quintana, María Jesús, Baré, Marisa, Vidal, Carmen, Natal, Carmen, Sánchez, Mar, Saladié, Francina, Ferrer, Joana, Vernet, Mar, Servitja, Sonia, Rodríguez-Arana, Ana, Roman, Marta, Espinàs, Josep Alfons, Sala, María
Publicado no Breast Cancer Res Treat (2014)

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma

Por Rojo, Federico, González-Pérez, Abel, Furriol, Jessica, Nicolau, Ma Jesús, Ferrer, Jaime, Burgués, Octavio, Sabbaghi, MohammadA, González-Navarrete, Irene, Cristobal, Ion, Serrano, Laia, Zazo, Sandra, Madoz, Juan, Servitja, Sonia, Tusquets, Ignasi, Albanell, Joan, Lluch, Ana, Rovira, Ana, Eroles, Pilar
Publicado no Br J Cancer (2016)

EuroDia: a beta-cell gene expression resource

Por Liechti, Robin, Csárdi, Gábor, Bergmann, Sven, Schütz, Frédéric, Sengstag, Thierry, Boj, Sylvia F., Servitja, Joan-Marc, Ferrer, Jorge, Van Lommel, Leentje, Schuit, Frans, Klinger, Sonia, Thorens, Bernard, Naamane, Najib, Eizirik, Decio L., Marselli, Lorella, Bugliani, Marco, Marchetti, Piero, Lucas, Stephanie, Holm, Cecilia, Jongeneel, C. Victor, Xenarios, Ioannis
Publicado em 2010

Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study

Por Dierssen-Sotos, Trinidad, Gómez-Acebo, Inés, de Pedro, María, Pérez-Gómez, Beatriz, Servitja, Sonia, Moreno, Víctor, Amiano, Pilar, Fernandez-Villa, Tania, Barricarte, Aurelio, Tardon, Adonina, Diaz-Santos, Marian, Peiro-Perez, Rosana, Marcos-Gragera, Rafael, Lope, Virginia, Gracia-Lavedan, Esther, Alonso, M. Henar, Michelena-Echeveste, Maria Jesus, Garcia-Palomo, Andrés, Guevara, Marcela, Castaño-Vinyals, Gemma, Aragonés, Nuria, Kogevinas, Manolis, Pollán, Marina, Llorca, Javier
Publicado no BMC Cancer (2016)